DK1334123T3 - Eukaryotiske celledelingsgener og deres anvendelse til diagnose og behandling af proliferative sygdomme - Google Patents
Eukaryotiske celledelingsgener og deres anvendelse til diagnose og behandling af proliferative sygdommeInfo
- Publication number
- DK1334123T3 DK1334123T3 DK01993708T DK01993708T DK1334123T3 DK 1334123 T3 DK1334123 T3 DK 1334123T3 DK 01993708 T DK01993708 T DK 01993708T DK 01993708 T DK01993708 T DK 01993708T DK 1334123 T3 DK1334123 T3 DK 1334123T3
- Authority
- DK
- Denmark
- Prior art keywords
- diagnosis
- treatment
- cell division
- proliferative diseases
- eukaryotic cell
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 5
- 230000032823 cell division Effects 0.000 title abstract 2
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 230000002062 proliferating effect Effects 0.000 title abstract 2
- 210000003527 eukaryotic cell Anatomy 0.000 title 1
- 238000002955 isolation Methods 0.000 abstract 2
- 230000001028 anti-proliverative effect Effects 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000007423 screening assay Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
- C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
- C07K14/43545—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes from Caenorhabditis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24675000P | 2000-11-09 | 2000-11-09 | |
| PCT/EP2001/013034 WO2002038805A2 (en) | 2000-11-09 | 2001-11-09 | Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1334123T3 true DK1334123T3 (da) | 2009-01-12 |
Family
ID=22932039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01993708T DK1334123T3 (da) | 2000-11-09 | 2001-11-09 | Eukaryotiske celledelingsgener og deres anvendelse til diagnose og behandling af proliferative sygdomme |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7368248B2 (enExample) |
| EP (1) | EP1334123B1 (enExample) |
| JP (1) | JP2004526421A (enExample) |
| AT (1) | ATE405585T1 (enExample) |
| AU (2) | AU2002224838B9 (enExample) |
| CA (1) | CA2428438C (enExample) |
| DE (1) | DE60135482D1 (enExample) |
| DK (1) | DK1334123T3 (enExample) |
| WO (1) | WO2002038805A2 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8202979B2 (en) | 2002-02-20 | 2012-06-19 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid |
| WO2003070918A2 (en) | 2002-02-20 | 2003-08-28 | Ribozyme Pharmaceuticals, Incorporated | Rna interference by modified short interfering nucleic acid |
| US7517864B2 (en) | 2001-05-18 | 2009-04-14 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA) |
| US20050148530A1 (en) | 2002-02-20 | 2005-07-07 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA) |
| US9994853B2 (en) | 2001-05-18 | 2018-06-12 | Sirna Therapeutics, Inc. | Chemically modified multifunctional short interfering nucleic acid molecules that mediate RNA interference |
| US9657294B2 (en) | 2002-02-20 | 2017-05-23 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| US9181551B2 (en) | 2002-02-20 | 2015-11-10 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| AU2003207708A1 (en) | 2002-02-20 | 2003-09-09 | Sirna Therapeutics, Inc. | Rna interference mediated inhibition of map kinase genes |
| JP2007511216A (ja) * | 2003-11-17 | 2007-05-10 | クルセイド ラボラトリーズ リミテッド | 変異ウイルス |
| JP2007523649A (ja) | 2004-02-10 | 2007-08-23 | サーナ・セラピューティクス・インコーポレイテッド | 多機能短鎖干渉核酸（多機能ｓｉＮＡ）を用い、ＲＮＡ干渉を介した遺伝子発現の阻害 |
| WO2005105157A2 (en) | 2004-04-23 | 2005-11-10 | The Trustees Of Columbia University In The City Ofnew York | INHIBITION OF HAIRLESS PROTEIN mRNA |
| US10508277B2 (en) | 2004-05-24 | 2019-12-17 | Sirna Therapeutics, Inc. | Chemically modified multifunctional short interfering nucleic acid molecules that mediate RNA interference |
| US9708619B2 (en) | 2005-09-20 | 2017-07-18 | Basf Plant Science Gmbh | Methods for controlling gene expression using ta-siRNA |
| DK2129680T3 (en) | 2007-03-21 | 2015-08-10 | Brookhaven Science Ass Llc | COMBINED hairpin ANTISENSE COMPOSITIONS AND METHODS FOR MODULATING EXPRESSION OF |
| KR101605932B1 (ko) | 2009-12-18 | 2016-03-24 | 노파르티스 아게 | Ｈｓｆ1-관련 질환을 치료하기 위한 유기 조성물 |
| AU2011214465A1 (en) | 2010-02-10 | 2012-08-30 | Novartis Ag | Methods and compounds for muscle growth |
| EP3766975A1 (en) | 2010-10-29 | 2021-01-20 | Sirna Therapeutics, Inc. | Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8910962D0 (en) | 1989-05-12 | 1989-06-28 | Natural Environment Res | Novel baculovirus expression vectors and use thereof in the expression of foreign proteins in insects or insect cells |
| US5162222A (en) * | 1989-07-07 | 1992-11-10 | Guarino Linda A | Use of baculovirus early promoters for expression of foreign genes in stably transformed insect cells or recombinant baculoviruses |
| US5155037A (en) * | 1989-08-04 | 1992-10-13 | The Texas A&M University System | Insect signal sequences useful to improve the efficiency of processing and secretion of foreign genes in insect systems |
| CA2311201A1 (en) * | 1999-08-05 | 2001-02-05 | Genset S.A. | Ests and encoded human proteins |
-
2001
- 2001-11-09 EP EP01993708A patent/EP1334123B1/en not_active Expired - Lifetime
- 2001-11-09 AU AU2002224838A patent/AU2002224838B9/en not_active Ceased
- 2001-11-09 WO PCT/EP2001/013034 patent/WO2002038805A2/en not_active Ceased
- 2001-11-09 DE DE60135482T patent/DE60135482D1/de not_active Expired - Lifetime
- 2001-11-09 US US10/415,657 patent/US7368248B2/en not_active Expired - Fee Related
- 2001-11-09 CA CA2428438A patent/CA2428438C/en not_active Expired - Fee Related
- 2001-11-09 JP JP2002542118A patent/JP2004526421A/ja active Pending
- 2001-11-09 AT AT01993708T patent/ATE405585T1/de not_active IP Right Cessation
- 2001-11-09 DK DK01993708T patent/DK1334123T3/da active
- 2001-11-09 AU AU2483802A patent/AU2483802A/xx active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE60135482D1 (de) | 2008-10-02 |
| WO2002038805A8 (en) | 2007-07-05 |
| EP1334123A2 (en) | 2003-08-13 |
| AU2483802A (en) | 2002-05-21 |
| AU2002224838B9 (en) | 2007-02-08 |
| CA2428438A1 (en) | 2002-05-16 |
| US7368248B2 (en) | 2008-05-06 |
| WO2002038805A2 (en) | 2002-05-16 |
| AU2002224838B2 (en) | 2006-07-27 |
| ATE405585T1 (de) | 2008-09-15 |
| WO2002038805A3 (en) | 2003-02-13 |
| US20040048277A1 (en) | 2004-03-11 |
| JP2004526421A (ja) | 2004-09-02 |
| EP1334123B1 (en) | 2008-08-20 |
| CA2428438C (en) | 2012-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2483802A (en) | Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases | |
| IL258880A (en) | Diarylhydantoin compounds | |
| NO20055731L (no) | Cannabinoide reseptorligander og deres anvendelse | |
| NO20081211L (no) | Xantinderivater som selektive HM74A agonister | |
| UA85559C2 (en) | Aminobenzophenone compounds | |
| BR0011838B1 (pt) | elemento de sela e estrutura de misturador estático. | |
| BRPI0607306A2 (pt) | derivados de quinoxalina como agentes anti-tumor | |
| ATE415397T1 (de) | Substituierte aryl- und heteroarylderivate als modulatoren des stoffwechsels und für die prophylaxe und behandlung von damit in zusammenhang stehenden erkrankungen | |
| BR0107943A (pt) | Sìtios de entrada de ribossoma internos sintéticos e métodos de identificar os mesmos | |
| NO20072548L (no) | Xantinderivater med HM74A reseptoraktivitet | |
| DE602004024909D1 (de) | Platinkomplexe zur behandlung von tumoren | |
| NO20055516L (no) | Kannabinoidreceptorligander og anvendelser derav | |
| DE602007012261D1 (de) | Triazolyl-pyridyl-benzolsulfonamide als ccr2- oder ccr9-modulatoren zur behandlung von atherosklerose | |
| DE602004029904D1 (de) | Neue tricyclische nukleoside oder nukleotide als therapeutische mittel | |
| NO20052928L (no) | Nye kjemiske forbindelser | |
| ATE411805T1 (de) | Organo-phosphorverbindungen zur aktivierung von gamma/delta-t-zellen | |
| EP1611120A4 (en) | NEW METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASES | |
| UA90698C2 (en) | Triazole substituted aminobenzophenone compounds | |
| NO20074780L (no) | Heterocyklylamidsubstituerte imidazoler | |
| TW200626900A (en) | Wnt proteins and detection and treatment of cancer | |
| CY1109187T1 (el) | Νεα μακρολιδια | |
| EA200500934A1 (ru) | Соединения, модулирующие активность киназного белка множественных линий, и способы лечения нейродегенеративных и воспалительных заболеваний | |
| WO2002090925A3 (en) | Polypeptides and nucleic acids associated with cancer | |
| EP1824498A4 (en) | METHOD AND COMPOSITIONS FOR TREATING PROLIFERATIVE CELL DISEASES | |
| EP1768679A4 (en) | MODULATION OF GSK-3B AND METHOD FOR THE TREATMENT OF PROLIFERATIVE DISEASES |